fluocinolone acetonide has been researched along with Cataract, Membranous in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 15 (68.18) | 24.3611 |
| 2020's | 3 (13.64) | 2.80 |
| Authors | Studies |
|---|---|
| Adán, A; Figueras-Roca, M; Miguel-Escuder, L; Moll-Udina, A; Navarro-Angulo, MJ; Olate-Pérez, Á; Pelegrín, L; Sala-Puigdoners, A | 1 |
| Buhl, L; Kern, C; Thurau, S | 1 |
| Heinz, C; Pavesio, C | 1 |
| Diplotti, L; Lanzetta, P; Samassa, F; Sarao, V; Veritti, D | 1 |
| Habib, MS | 1 |
| Barnes, AC; Baynes, K; Bessette, AP; Lowder, CY; Srivastava, SK | 1 |
| Aziz, K; Bajwa, A; Foster, CS | 1 |
| Bailey, C; Loewenstein, A; Massin, P; Yang, Y | 1 |
| Abreu, FM; Altaweel, MM; Elner, SG; Holbrook, JT; Jabs, DA; Kempen, JH; Kim, RY; Louis, TA; Sen, HN; Sugar, EA | 1 |
| Chang, PY; Huang, TL; Su, PY; Wang, JK | 1 |
| Chang, IT; Chen, PP; Gupta, D; Slabaugh, MA; Vemulakonda, GA | 1 |
| Carlson, AN; Chieh, JJ; Jaffe, GJ | 1 |
| Flynn, HW; Schwartz, SG | 1 |
| Kadam, R; Kompella, UB; Thakur, A | 1 |
| Ashton, P; Callanan, D; Comstock, TL; Eliott, D; Ip, M; Levy, B; Mann, ES; Morse, LS; Pearson, PA | 1 |
| Bailey, C; Billman, K; Boyer, D; Brown, DM; Campochiaro, PA; Chen, S; Garretson, B; Green, K; Gupta, A; Hariprasad, SM; Kane, FE; Kapik, B; Pearson, A; Reichel, E; Ruiz-Moreno, J; Soubrane, G | 1 |
| Abrams, GW; Ahmad, ZM; Hughes, BA; Mahmoud, TH | 1 |
| Arcinue, CA; Cerón, OM; Foster, CS | 1 |
| Holekamp, NM; Pearson, A; Thomas, MA | 1 |
| Ashton, P; Branchaud, B; Butuner, Z; Jaffe, GJ; McCallum, RM; Skalak, C | 1 |
| Callanan, D; Comstock, T; Jaffe, GJ; Levy, B; Martin, D; Pearson, PA | 1 |
5 review(s) available for fluocinolone acetonide and Cataract, Membranous
| Article | Year |
|---|---|
Fluocinolone acetonide for the treatment of diabetic macular edema.
Topics: Cataract; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Glaucoma; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Visual Acuity | 2017 |
ILUVIEN
Topics: Angiogenesis Inhibitors; Cataract; Clinical Trials, Phase II as Topic; Cost-Benefit Analysis; Delayed-Action Preparations; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Models, Economic; Quality of Life; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2018 |
INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: PHARMACOKINETIC CONSIDERATIONS.
Topics: Cataract; Dexamethasone; Diabetic Retinopathy; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Triamcinolone Acetonide; Visual Acuity | 2015 |
An updated review of long-term outcomes from randomized controlled trials in approved pharmaceuticals for diabetic macular edema.
Topics: Cataract; Dexamethasone; Diabetic Retinopathy; Fluocinolone Acetonide; Glaucoma; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Randomized Controlled Trials as Topic; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Time Factors; Treatment Outcome; Vascular Endothelial Growth Factor A | 2015 |
Fluocinolone acetonide implantable device for diabetic retinopathy.
Topics: Cataract; Diabetic Retinopathy; Drug Administration Routes; Drug Delivery Systems; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Randomized Controlled Trials as Topic; Vascular Endothelial Growth Factor A; Vitreous Body | 2011 |
8 trial(s) available for fluocinolone acetonide and Cataract, Membranous
| Article | Year |
|---|---|
Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatmen
Topics: Adult; Aged; Anti-Inflammatory Agents; Cataract; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Panuveitis; Prednisone; Prospective Studies; Quality of Life; Risk Factors; Uveitis, Intermediate; Uveitis, Posterior; Visual Acuity | 2015 |
Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial.
Topics: Adult; Cataract; Cataract Extraction; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome; Uveitis; Visual Acuity | 2016 |
Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
Topics: Adolescent; Adult; Aged; Cataract; Delayed-Action Preparations; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intraoperative Complications; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Uveitis; Visual Acuity | 2008 |
Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial.
Topics: Cataract; Diabetic Retinopathy; Double-Blind Method; Drug Implants; Female; Fluocinolone Acetonide; Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Retina; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Vitreous Body | 2011 |
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema.
Topics: Antihypertensive Agents; Cataract; Diabetic Retinopathy; Double-Blind Method; Drug Implants; Fluocinolone Acetonide; Fluorescein Angiography; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Macular Edema; Phacoemulsification; Tomography, Optical Coherence; Trabeculectomy; Treatment Outcome; Visual Acuity; Vitreous Body | 2012 |
The safety profile of long-term, high-dose intraocular corticosteroid delivery.
Topics: Adult; Angioid Streaks; Cataract; Choroid Diseases; Choroidal Neovascularization; Drug Delivery Systems; Drug Implants; Feasibility Studies; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Histoplasmosis; Humans; Intraocular Pressure; Male; Middle Aged; Myopia, Degenerative; Ocular Hypertension; Prospective Studies; Retinal Vein Occlusion; Safety; Treatment Outcome; Visual Acuity | 2005 |
Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
Topics: Adolescent; Adult; Aged; Cataract; Double-Blind Method; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Pilot Projects; Prospective Studies; Safety; Treatment Outcome; Uveitis, Posterior; Visual Acuity; Vitreous Body | 2005 |
Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract; Child; Double-Blind Method; Drug Implants; Female; Filtering Surgery; Fluocinolone Acetonide; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Lens, Crystalline; Male; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome; Uveitis, Posterior; Visual Acuity | 2006 |
9 other study(ies) available for fluocinolone acetonide and Cataract, Membranous
| Article | Year |
|---|---|
Intravitreal fluocinolone acetonide implant for the treatment of persistent post-surgical cystoid macular edema in vitrectomized eyes.
Topics: Cataract; Dexamethasone; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema | 2023 |
Fluocinolone acetonide 0.19-mg implant for the treatment of noninfectious uveitis with involvement of the posterior segment: a real-world study.
Topics: Cataract; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Inflammation; Intraocular Pressure; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome; Uveitis; Uveitis, Posterior | 2023 |
Non-infectious uveitis affecting the posterior segment treated with fluocinolone acetonide intravitreal implant: 3-year fellow eye analysis.
Topics: Cataract; Drug Implants; Eye Infections, Bacterial; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Recurrence; Treatment Outcome; Uveitis; Visual Acuity | 2022 |
Treatment of Acute Zonal Occult Outer Retinopathy With Intravitreal Steroids.
Topics: Adult; Aged; Cataract; Dexamethasone; Drug Implants; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Scotoma; Tomography, Optical Coherence; Visual Acuity; White Dot Syndromes | 2018 |
Safety and efficacy of fluocinolone acetonide intravitreal implant (0.59 mg) in birdshot retinochoroidopathy.
Topics: Adult; Aged; Anti-Inflammatory Agents; Birdshot Chorioretinopathy; Cataract; Chorioretinitis; Delayed-Action Preparations; Drug Implants; Electroretinography; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity; Visual Fields | 2014 |
Combined Ahmed Glaucoma Valve Placement, Intravitreal Fluocinolone Acetonide Implantation and Cataract Extraction for Chronic Uveitis.
Topics: Adult; Cataract; Cataract Extraction; Chronic Disease; Drug Implants; Female; Filtering Surgery; Fluocinolone Acetonide; Glaucoma; Glaucoma Drainage Implants; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Retrospective Studies; Tonometry, Ocular; Treatment Outcome; Uveitis; Visual Acuity; Young Adult | 2016 |
Trabecular meshwork and lens partitioning of corticosteroids: implications for elevated intraocular pressure and cataracts.
Topics: Animals; Budesonide; Cataract; Cattle; Chromatography, High Pressure Liquid; Dexamethasone; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Lens, Crystalline; Middle Aged; Prednisolone; Tandem Mass Spectrometry; Trabecular Meshwork; Triamcinolone Acetonide | 2011 |
Combined posterior chamber intraocular lens, vitrectomy, Retisert, and pars plana tube in noninfectious uveitis.
Topics: Adult; Anesthesia, Local; Antihypertensive Agents; Cataract; Cataract Extraction; Chronic Disease; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Posterior Eye Segment; Postoperative Complications; Retrospective Studies; Sclerostomy; Suture Techniques; Treatment Outcome; Uveitis, Posterior; Visual Acuity; Vitrectomy; Vitreous Body | 2012 |
A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Cataract; Dexamethasone; Disease Progression; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Retrospective Studies; Secondary Prevention; Time Factors; Treatment Outcome; Uveitis; Visual Acuity | 2013 |